Odyssey boat greece
Biotech

Odyssey CEO sees $304M IPO creating ‘little large pharma’

Odyssey Therapeutics has become the latest biotech to voyage to the public markets via an upsized $304 million IPO this morning.
James Waldron , Will Maddox May 8, 2026 7:27am
AstraZeneca RD robot

From R&D to M&A: Big Pharmas showcase ‘measurable impact’ of AI

May 7, 2026 9:10am
Marty Makary FDA Commissioner
Favicon Fierce Pharma

Trump plans to end stormy 14-month tenure of FDA chief Makary

May 8, 2026 3:38pm
Lab mouse running through a maze

Protective gene sent to the liver cleared brain amyloid in mice

May 8, 2026 1:15pm
downfall

EnGene cancer sales forecast cut after new data widen gap to J&J

May 8, 2026 9:08am
Illustration for Fierces Chutes Ladders feature showing a blue city skyline with executives making career moves o

Biopharma veteran takes her CEO Cue—Chutes & Ladders

May 8, 2026 8:30am
More News

Banyan BioInnovations launches with $100M, Icon collab

May 7, 2026 2:13pm

BeOne shelves 5 cancer programs, halts ph. 2 arthritis trial

May 7, 2026 11:15am

New antibodies stop measles from stabbing cells, study finds

May 7, 2026 11:00am
Fierce Pharma

FDA to reconsider rejected cell therapy. Could uniQure be next?

May 7, 2026 10:40am